• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy.Bcl-2过表达可阻断光动力疗法引发的半胱天冬酶激活及下游凋亡事件。
Br J Cancer. 1999 Jan;79(1):95-100. doi: 10.1038/sj.bjc.6690017.
2
Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA.
FEBS Lett. 1998 Jan 30;422(2):151-4. doi: 10.1016/s0014-5793(97)01616-5.
3
Photodynamic therapy induces caspase-3 activation in HL-60 cells.光动力疗法可诱导HL-60细胞中的半胱天冬酶-3激活。
Cell Death Differ. 1997 Oct;4(7):623-8. doi: 10.1038/sj.cdd.4400286.
4
Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.Bcl-2或Bcl-xL的过表达可抑制阿糖胞苷诱导的CPP32/Yama蛋白酶活性及人急性髓性白血病HL-60细胞的凋亡。
Cancer Res. 1996 Oct 15;56(20):4743-8.
5
Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity.线粒体细胞色素c的早期释放以及线粒体表位7A6与卟啉衍生光敏剂的表达:Bcl-2和Bcl-xL的过表达不能阻止早期线粒体事件,但仍会抑制半胱天冬酶活性。
Lab Invest. 1999 Aug;79(8):953-65.
6
Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.Bcl-2和Bcl-xL的异位表达通过抑制半胱天冬酶-8、7和3以及人急性髓性白血病细胞系HL-60中的BID裂解,抑制肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡。
J Interferon Cytokine Res. 2002 Feb;22(2):269-79. doi: 10.1089/107999002753536248.
7
Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.锰诱导人B细胞凋亡:bcl-2阻断半胱天冬酶依赖性细胞死亡。
Cell Death Differ. 1999 May;6(5):445-53. doi: 10.1038/sj.cdd.4400508.
8
Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer.使用免疫调节性光敏剂在体外对胸腺细胞亚群进行选择性清除。
Clin Immunol. 1999 May;91(2):178-87. doi: 10.1006/clim.1999.4695.
9
Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin.光化学治疗药物维替泊芬对核因子-κB的激活作用
Blood. 2000 Jan 1;95(1):256-62.
10
Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.Bcl-xL过表达抑制导致紫杉醇诱导人急性髓性白血病HL-60细胞凋亡的分子事件进展。
Cancer Res. 1997 Mar 15;57(6):1109-15.

引用本文的文献

1
Determinants of Photodynamic Therapy Resistance in Cancer Cells.癌症细胞光动力疗法抵抗的决定因素。
Int J Mol Sci. 2024 Nov 10;25(22):12069. doi: 10.3390/ijms252212069.
2
The role of yes activated protein (YAP) in melanoma metastasis.Yes 激活蛋白(YAP)在黑色素瘤转移中的作用。
iScience. 2024 Apr 30;27(6):109864. doi: 10.1016/j.isci.2024.109864. eCollection 2024 Jun 21.
3
Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation.Bcl-2 家族蛋白在光动力疗法介导的细胞存活和调控中的作用。
Molecules. 2020 Nov 13;25(22):5308. doi: 10.3390/molecules25225308.
4
Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells.脱镁叶绿酸a与阿霉素联合治疗肿瘤细胞的光动力协同效应
Cancers (Basel). 2017 Feb 17;9(2):18. doi: 10.3390/cancers9020018.
5
Effect of minocycline on cerebral ischemia-reperfusion injury.米诺环素对脑缺血再灌注损伤的影响。
Neural Regen Res. 2013 Apr 5;8(10):900-8. doi: 10.3969/j.issn.1673-5374.2013.10.004.
6
Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.光动力疗法在肺癌细胞中的靶点和机制:简要概述。
Cancers (Basel). 2011 Mar 3;3(1):1014-41. doi: 10.3390/cancers3011014.
7
Cell death pathways in photodynamic therapy of cancer.细胞死亡途径在癌症光动力疗法中的作用。
Cancers (Basel). 2011;3(2):2516-39. doi: 10.3390/cancers3022516.
8
Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence Tomography.利用光学相干断层扫描技术对光动力疗法反应进行无标记纵向体外可视化
Isr J Chem. 2012 Sep;52(8-9):728-744. doi: 10.1002/ijch.201200009. Epub 2012 Sep 13.
9
Mechanisms of resistance to photodynamic therapy.光动力疗法耐药机制。
Curr Med Chem. 2011;18(16):2486-515. doi: 10.2174/092986711795843272.
10
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.三维微转移卵巢癌模型中光动力疗法与卡铂协同增效作用的研究。
Cancer Res. 2010 Nov 15;70(22):9319-28. doi: 10.1158/0008-5472.CAN-10-1783. Epub 2010 Nov 9.

本文引用的文献

1
Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis.Bcl-2可防止在星形孢菌素介导的细胞凋亡中CPP32半胱氨酸蛋白酶的激活以及聚(ADP-核糖)聚合酶和U1-70 kD蛋白的裂解。
Cell Death Differ. 1997 Jan;4(1):34-8. doi: 10.1038/sj.cdd.4400205.
2
Bcl-2 acts upstream of the PARP protease and prevents its activation.Bcl-2在PARP蛋白酶上游发挥作用,并阻止其激活。
Cell Death Differ. 1997 Jan;4(1):29-33. doi: 10.1038/sj.cdd.4400200.
3
Photodynamic therapy induces caspase-3 activation in HL-60 cells.光动力疗法可诱导HL-60细胞中的半胱天冬酶-3激活。
Cell Death Differ. 1997 Oct;4(7):623-8. doi: 10.1038/sj.cdd.4400286.
4
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells.柯萨奇病毒B3感染HeLa细胞后诱导细胞病变效应,继而引发半胱天冬酶激活及底物特异性切割。
J Virol. 1998 Sep;72(9):7669-75. doi: 10.1128/JVI.72.9.7669-7675.1998.
5
CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45.CPAN,一种受半胱天冬酶敏感抑制剂DFF45调控的人类核酸酶。
Curr Biol. 1998 Apr 23;8(9):537-40. doi: 10.1016/s0960-9822(98)79298-x.
6
Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells.使用苯并卟啉衍生物单酸环A进行光动力治疗可在小鼠P815细胞中产生蛋白质酪氨酸磷酸化事件和DNA片段化。
Photochem Photobiol. 1998 Mar;67(3):358-62.
7
Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA.
FEBS Lett. 1998 Jan 30;422(2):151-4. doi: 10.1016/s0014-5793(97)01616-5.
8
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis.凋亡过程中CAD激活及DNA降解时CAD抑制剂的裂解
Nature. 1998 Jan 1;391(6662):96-9. doi: 10.1038/34214.
9
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.一种在细胞凋亡过程中降解DNA的半胱天冬酶激活的脱氧核糖核酸酶及其抑制剂ICAD。
Nature. 1998 Jan 1;391(6662):43-50. doi: 10.1038/34112.
10
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.细胞色素c和dATP依赖的Apaf-1/半胱天冬酶-9复合物的形成启动凋亡蛋白酶级联反应。
Cell. 1997 Nov 14;91(4):479-89. doi: 10.1016/s0092-8674(00)80434-1.

Bcl-2过表达可阻断光动力疗法引发的半胱天冬酶激活及下游凋亡事件。

Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy.

作者信息

Granville D J, Jiang H, An M T, Levy J G, McManus B M, Hunt D W

机构信息

QLT Photo Therapeutics, Vancouver, BC, Canada.

出版信息

Br J Cancer. 1999 Jan;79(1):95-100. doi: 10.1038/sj.bjc.6690017.

DOI:10.1038/sj.bjc.6690017
PMID:10408699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2362171/
Abstract

Treatment with the photosensitizer benzoporphyrin derivative monoacid ring A (BPD-MA, verteporfin) followed by irradiation with visible light induces apoptosis in human acute myelogenous leukaemia HL-60 cells. Photoactivation of BPD-MA induces procaspase 3 (CPP32/Yama/apopain) and procaspase 6 (Mch2) cleavage into their proteolytically active subunits in these cells. The Bcl-2 proto-oncogene product has been shown to protect cells from a number of proapoptotic stimuli. In the present study, the influence of Bcl-2 overexpression on cellular resistance to photoactivation of BPD-MA was studied. Overexpression of Bcl-2 in HL-60 cells prevented apoptosis-related events including caspase 3 and 6 activation, poly(ADP-ribose) polymerase cleavage and the formation of hypodiploid DNA produced by BPD-MA (0-200 ng ml(-1)) and light. However, Bcl-2 overexpression was less effective at preventing cell death that occurred after photoactivation at high levels (50-100 ng ml(-1)) compared with lower doses (10-25 ng ml(-1)) of BPD-MA. These results indicate that caspase 3 and 6 activation and their regulation by Bcl-2 may play important roles in photodynamic therapy (PDT)-induced cell killing.

摘要

用光敏剂苯并卟啉衍生物单酸环A(BPD - MA,维替泊芬)处理,随后用可见光照射,可诱导人急性髓性白血病HL - 60细胞凋亡。在这些细胞中,BPD - MA的光激活可诱导半胱天冬酶原3(CPP32/Yama/凋亡蛋白酶)和半胱天冬酶原6(Mch2)裂解为其蛋白水解活性亚基。已证明Bcl - 2原癌基因产物可保护细胞免受多种促凋亡刺激。在本研究中,研究了Bcl - 2过表达对细胞抵抗BPD - MA光激活的影响。HL - 60细胞中Bcl - 2的过表达可预防凋亡相关事件,包括半胱天冬酶3和6的激活、聚(ADP - 核糖)聚合酶的裂解以及由BPD - MA(0 - 200 ng ml(-1))和光照产生的亚二倍体DNA的形成。然而,与较低剂量(10 - 25 ng ml(-1))的BPD - MA相比,Bcl - 2过表达在预防高水平(50 - 100 ng ml(-1))光激活后发生的细胞死亡方面效果较差。这些结果表明半胱天冬酶3和6的激活及其受Bcl - 2的调节可能在光动力疗法(PDT)诱导的细胞杀伤中起重要作用。